New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19
Multiple Sclerosis and Related Disorders(2022)
摘要
•Vaccination to prevent severe cases of COVID-19 is key to controlling the pandemic.•Some vaccines may trigger rare autoimmune adverse events.•AZD1222 is here reported to trigger relapses of MS and NMOSD.
更多查看译文
关键词
Multiple sclerosis,Neuromyelitis optica,COVID-19,Vaccine,Relapse
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要